The Role of Belimumab in Systemic Lupus Erythematosis: A Systematic Review
Author:
Publisher
Cureus, Inc.
Subject
Aerospace Engineering
Reference38 articles.
1. Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of care;Bruce IN;Lupus,2016
2. Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial;Brunner HI;Ann Rheum Dis,2020
3. Suppression of serum interferon-γ levels as a potential measure of response to ustekinumab treatment in patients with systemic lupus erythematosus;Cesaroni M;Arthritis Rheumatol,2021
4. Brief report: a randomized, double-blind, parallel-group, placebo-controlled, multiple-dose study to evaluate AMG 557 in patients with systemic lupus erythematosus and active lupus arthritis;Cheng LE;Arthritis Rheumatol,2018
5. Efficacy and safety of epratuzumab in moderately to severely active systemic lupus erythematosus: results from two phase III randomized, double-blind, placebo-controlled trials;Clowse ME;Arthritis Rheumatol,2017
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Expression of B-cell activating factor (BAFF) in proliferative lupus nephritis, revisited;Alexandria Journal of Medicine;2024-06-11
2. Nefritis Lúpica : Una Revisión Sistemática de su Manejo;Revista de la Facultad de Medicina;2024-05-31
3. Can the dose of belimumab be reduced in patients with systemic lupus erythematosus?;Rheumatology;2024-05-13
4. The role of BAFF and BAFF-R inhibitors in the treatment of immune thrombocytopenia; a focused review;International Immunopharmacology;2024-04
5. Safety, Tolerability, Pharmacokinetics, and Immunogenicity of the Anti-IFNAR1 Monoclonal Antibody QX006N: A First-in-Human Single Ascending Dose Study in Healthy Chinese Volunteers;BioDrugs;2023-12-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3